-
1
-
-
0028775544
-
The treatment of multiple myeloma
-
Alexanian R, Dimopoulos M. The treatment of multiple myeloma. New Engl J Med 1994; 330: 484-489.
-
(1994)
New Engl J Med
, vol.330
, pp. 484-489
-
-
Alexanian, R.1
Dimopoulos, M.2
-
2
-
-
0026585927
-
Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: An overview of published trials
-
Gregory WM, Richards MA, Malpas JS. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol 1992; 10: 334-342.
-
(1992)
J Clin Oncol
, vol.10
, pp. 334-342
-
-
Gregory, W.M.1
Richards, M.A.2
Malpas, J.S.3
-
3
-
-
0026070258
-
Allogeneic bone marrow transplantation in multiple myeloma
-
Gahrton G, Tura S, Ljungman P et al. Allogeneic bone marrow transplantation in multiple myeloma. New Engl J Med 1991; 325: 1267-1273.
-
(1991)
New Engl J Med
, vol.325
, pp. 1267-1273
-
-
Gahrton, G.1
Tura, S.2
Ljungman, P.3
-
4
-
-
0027057481
-
Phase I study of busulphan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma
-
Bensinger WI, Buckner CD, Clift RA et al. Phase I study of busulphan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma. J Clin Oncol 1992; 10: 1492-497.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1492-1497
-
-
Bensinger, W.I.1
Buckner, C.D.2
Clift, R.A.3
-
5
-
-
0020578180
-
High-dose intravenous melphalan for plasma-cell leukaemia and myeloma
-
McElwain TJ, Powles RL. High-dose intravenous melphalan for plasma-cell leukaemia and myeloma. Lancet 1983; 2: 822-824.
-
(1983)
Lancet
, vol.2
, pp. 822-824
-
-
McElwain, T.J.1
Powles, R.L.2
-
6
-
-
85047693579
-
Multiple myeloma treated with high dose intravenous melphalan
-
Selby P, McElwain TJ, Nandi AC et al. Multiple myeloma treated with high dose intravenous melphalan. Br J Haematol 1987; 66: 55-62.
-
(1987)
Br J Haematol
, vol.66
, pp. 55-62
-
-
Selby, P.1
McElwain, T.J.2
Nandi, A.C.3
-
7
-
-
0022510876
-
High dose melphalan with autologous bone marrow transplantation for multiple myeloma
-
Barlogie B, Hall R, Zander A et al. High dose melphalan with autologous bone marrow transplantation for multiple myeloma. Blood 1986; 67: 1298-1301.
-
(1986)
Blood
, vol.67
, pp. 1298-1301
-
-
Barlogie, B.1
Hall, R.2
Zander, A.3
-
8
-
-
0024350166
-
Intensive treatment of multiple myeloma and criteria for complete remission
-
Gore ME, Selby PJ, Viner C et al. Intensive treatment of multiple myeloma and criteria for complete remission. Lancet 1989; 2: 879-82.
-
(1989)
Lancet
, vol.2
, pp. 879-882
-
-
Gore, M.E.1
Selby, P.J.2
Viner, C.3
-
9
-
-
0025203141
-
Autologous bone marrow transplantation in multiple myeloma: Identification of prognostic factors
-
Jagannath S, Barlogie B, Dicke K et al. Autologous bone marrow transplantation in multiple myeloma: identification of prognostic factors. Blood 1990; 76: 1860-1866.
-
(1990)
Blood
, vol.76
, pp. 1860-1866
-
-
Jagannath, S.1
Barlogie, B.2
Dicke, K.3
-
10
-
-
0026570466
-
Intensive combined therapy for previously untreated aggressive myeloma
-
Attal M, Huguet F, Schlaifer D et al. Intensive combined therapy for previously untreated aggressive myeloma. Blood 1992; 79: 1130-1136.
-
(1992)
Blood
, vol.79
, pp. 1130-1136
-
-
Attal, M.1
Huguet, F.2
Schlaifer, D.3
-
11
-
-
0026729417
-
Double-intensive therapy in high-risk multiple myeloma
-
Harousseau JL, Milpied N, Laporte JP et al. Double-intensive therapy in high-risk multiple myeloma. Blood 1992; 79: 2827-2833.
-
(1992)
Blood
, vol.79
, pp. 2827-2833
-
-
Harousseau, J.L.1
Milpied, N.2
Laporte, J.P.3
-
12
-
-
0027367897
-
High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: Results of a phase II trial involving 63 patients
-
Fermand JP, Chevret S, Ravaud P et al. High-dose chemoradiotherapy and autologous blood stem cell transplantation in multiple myeloma: results of a phase II trial involving 63 patients. Blood 1993; 82: 2005-2009.
-
(1993)
Blood
, vol.82
, pp. 2005-2009
-
-
Fermand, J.P.1
Chevret, S.2
Ravaud, P.3
-
13
-
-
0027027417
-
A comparison of peripheral blood stem cell mobilization after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer
-
Rowlings PA, Rawling CM, To LB et al. A comparison of peripheral blood stem cell mobilization after chemotherapy with cyclophosphamide as a single agent in doses of 4 g/m2 or 7 g/m2 in patients with advanced cancer. Aust NZ J Med 1992; 22: 660-664.
-
(1992)
Aust NZ J Med
, vol.22
, pp. 660-664
-
-
Rowlings, P.A.1
Rawling, C.M.2
To, L.B.3
-
14
-
-
0024495749
-
The optimisation of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia
-
To LB, Haylock DN, Thorp DL et al. The optimisation of collection of peripheral blood stem cells for autotransplantation in acute myeloid leukaemia. Bone Marrow Transplant 1989; 4: 41-47.
-
(1989)
Bone Marrow Transplant
, vol.4
, pp. 41-47
-
-
To, L.B.1
Haylock, D.N.2
Thorp, D.L.3
-
15
-
-
0025126768
-
Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells fom the peripheral blood
-
To LB, Shepperd KM, Haylock DN et al. Single high doses of cyclophosphamide enable the collection of high numbers of hemopoietic stem cells fom the peripheral blood. Exp Hematol 1990; 18: 442-447.
-
(1990)
Exp Hematol
, vol.18
, pp. 442-447
-
-
To, L.B.1
Shepperd, K.M.2
Haylock, D.N.3
-
16
-
-
0027025074
-
Defining a therapeutic dose of peripheral blood stem cells
-
Bender JG, To LB, Williams S et al. Defining a therapeutic dose of peripheral blood stem cells. J Hematother 1992; 1: 329-342.
-
(1992)
J Hematother
, vol.1
, pp. 329-342
-
-
Bender, J.G.1
To, L.B.2
Williams, S.3
-
17
-
-
8944248977
-
Busulphan/cyclophosphamide conditioning followed by transplantation of autologous peripheral blood progenitor cells as treatment for advanced multiple myeloma
-
Schiller G, Lieb G, Lee M et al. Busulphan/cyclophosphamide conditioning followed by transplantation of autologous peripheral blood progenitor cells as treatment for advanced multiple myeloma. Blood 1992; 80: 121a.
-
(1992)
Blood
, vol.80
-
-
Schiller, G.1
Lieb, G.2
Lee, M.3
-
18
-
-
8944226761
-
Myeloablative high-dose therapy (HDT) and autologous peripheral blood mononuclear cell (PBMC) rescue for multiple myeloma (MM)
-
Abstr. 1234
-
Long GD, Chao NJ, Negrin RS, Blume KG. Myeloablative high-dose therapy (HDT) and autologous peripheral blood mononuclear cell (PBMC) rescue for multiple myeloma (MM). Proc ASCO 1993; 12: 365 (Abstr. 1234).
-
(1993)
Proc ASCO
, vol.12
, pp. 365
-
-
Long, G.D.1
Chao, N.J.2
Negrin, R.S.3
Blume, K.G.4
-
19
-
-
8944259597
-
Autologous peripheral blood stem cell (PBSC) transplantation as first line treatment of multiple myeloma: Preliminary results of an Italian multicenter pilot study
-
Abstr. 1382
-
Tribalto M, Avvisati G, Papa G et al. Autologous peripheral blood stem cell (PBSC) transplantation as first line treatment of multiple myeloma: preliminary results of an Italian multicenter pilot study. Proc ASCO 1993; 12: 404 (Abstr. 1382).
-
(1993)
Proc ASCO
, vol.12
, pp. 404
-
-
Tribalto, M.1
Avvisati, G.2
Papa, G.3
-
20
-
-
0028335012
-
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma
-
Gianni AM, Tarella C, Bregni M et al. High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma. J Clin Oncol 1994; 12: 503-509.
-
(1994)
J Clin Oncol
, vol.12
, pp. 503-509
-
-
Gianni, A.M.1
Tarella, C.2
Bregni, M.3
-
21
-
-
0026733455
-
Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support
-
Jagannath S, Vesole DH, Glenn L et al. Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 1992; 80: 1666-1672.
-
(1992)
Blood
, vol.80
, pp. 1666-1672
-
-
Jagannath, S.1
Vesole, D.H.2
Glenn, L.3
-
22
-
-
0027435042
-
Thiotepa, busulphan, and cyclophosphamide: A new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma
-
Dimopoulos MA, Alexanian R, Przepiorka D et al. Thiotepa, busulphan, and cyclophosphamide: a new preparative regimen for autologous marrow or blood stem cell transplantation in high-risk multiple myeloma. Blood 1993; 82: 2324-2328.
-
(1993)
Blood
, vol.82
, pp. 2324-2328
-
-
Dimopoulos, M.A.1
Alexanian, R.2
Przepiorka, D.3
-
23
-
-
0028069256
-
Limited value of myeloablative therapy for late multiple myeloma
-
Alexanian R, Dimopoulos M, Smith T et al. Limited value of myeloablative therapy for late multiple myeloma. Blood 1994; 83: 512-516.
-
(1994)
Blood
, vol.83
, pp. 512-516
-
-
Alexanian, R.1
Dimopoulos, M.2
Smith, T.3
-
24
-
-
84983963471
-
Blood stem cell transplants in myeloma
-
Gale RP, Juttner CA, Henon P (eds). Cambridge University Press: Cambridge
-
Barlogie B, Fermand JP, Henon P et al. Blood stem cell transplants in myeloma. In: Gale RP, Juttner CA, Henon P (eds). Blood Stem Cell Transplants. Cambridge University Press: Cambridge, 1994, pp 150-163.
-
(1994)
Blood Stem Cell Transplants
, pp. 150-163
-
-
Barlogie, B.1
Fermand, J.P.2
Henon, P.3
-
25
-
-
0027275603
-
Collection of peripheral blood stem cells in multiple myeloma following high-dose cyclophosphamide with or without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF)
-
Boiron JM, Marit G, Faberes C et al. Collection of peripheral blood stem cells in multiple myeloma following high-dose cyclophosphamide with or without recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF). Bone Marrow Transplant 1993; 12: 49-55.
-
(1993)
Bone Marrow Transplant
, vol.12
, pp. 49-55
-
-
Boiron, J.M.1
Marit, G.2
Faberes, C.3
-
26
-
-
0025219465
-
Recombinant human granulocyte macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma
-
Gianni AM, Bregni M, Siena S et al. Recombinant human granulocyte macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. J Clin Oncol 1990; 8: 768-778.
-
(1990)
J Clin Oncol
, vol.8
, pp. 768-778
-
-
Gianni, A.M.1
Bregni, M.2
Siena, S.3
-
27
-
-
0028029787
-
Prognostic factors in autologous stem cell transplantation for multiple myeloma: An EBMT Registry Study
-
European Group for Bone Marrow Transplantation.
-
Bjorkstrand B, Goldstone AH, Ljungman P et al. Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow Transplantation. Leuk Lymphoma 1994; 15: 265-72.
-
(1994)
Leuk Lymphoma
, vol.15
, pp. 265-272
-
-
Bjorkstrand, B.1
Goldstone, A.H.2
Ljungman, P.3
-
28
-
-
0026080877
-
Bone marrow transplantation in multiple myeloma
-
Barlogie B, Gahrton G. Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 1991; 7: 71-79.
-
(1991)
Bone Marrow Transplant
, vol.7
, pp. 71-79
-
-
Barlogie, B.1
Gahrton, G.2
-
29
-
-
0002856621
-
Prospective randomized comparison of MACOP-B versus rhGM-CSF supported high-dose sequential myeloablative chemoradiotherapy in diffuse large cell lymphomas
-
Abstr. 951
-
Gianni AM, Bregni M, Siena S et al. Prospective randomized comparison of MACOP-B versus rhGM-CSF supported high-dose sequential myeloablative chemoradiotherapy in diffuse large cell lymphomas. Proc ASCO 1991; 10: 274 (Abstr. 951).
-
(1991)
Proc ASCO
, vol.10
, pp. 274
-
-
Gianni, A.M.1
Bregni, M.2
Siena, S.3
-
30
-
-
0028155974
-
Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: A feasibility study
-
Ayash LJ, Elias A, Wheeler C et al. Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study. J Clin Oncol 1994; 12: 37-44.
-
(1994)
J Clin Oncol
, vol.12
, pp. 37-44
-
-
Ayash, L.J.1
Elias, A.2
Wheeler, C.3
-
31
-
-
0028963126
-
Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma
-
Bjorkstrand B, Ljungman P, Bird J et al. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remissions in multiple myeloma. Bone Marrow Transplant 1995; 15: 367-371.
-
(1995)
Bone Marrow Transplant
, vol.15
, pp. 367-371
-
-
Bjorkstrand, B.1
Ljungman, P.2
Bird, J.3
-
32
-
-
0027496486
-
Monoclonal antibody purged bone marrow transplantation therapy for multiple myeloma
-
Anderson KC, Andersen J, Soiffer R et al. Monoclonal antibody purged bone marrow transplantation therapy for multiple myeloma. Blood 1993; 82: 2568.
-
(1993)
Blood
, vol.82
, pp. 2568
-
-
Anderson, K.C.1
Andersen, J.2
Soiffer, R.3
-
33
-
-
0342361404
-
A comparison of engraftment following high dose chemotherapy with autologous bone marrow transplantation with either full bone marrow or CD34+ cells isolated with the Baxter Isolex 300™
-
Abstr. 362
-
Broun ER, Traycoff C, Graves V et al. A comparison of engraftment following high dose chemotherapy with autologous bone marrow transplantation with either full bone marrow or CD34+ cells isolated with the Baxter Isolex 300™. Exp Hematol 1994; 22: 775 (Abstr. 362).
-
(1994)
Exp Hematol
, vol.22
, pp. 775
-
-
Broun, E.R.1
Traycoff, C.2
Graves, V.3
-
34
-
-
0003337838
-
A randomised trial of maintainance therapy with Intron-A following high dose melphalan and ABMT in myeloma
-
Abstr. 1232
-
Cunningham D, Powles R, Malpas JS et al. A randomised trial of maintainance therapy with Intron-A following high dose melphalan and ABMT in myeloma. Proc ASCO 1993; 12: 364 (Abstr. 1232).
-
(1993)
Proc ASCO
, vol.12
, pp. 364
-
-
Cunningham, D.1
Powles, R.2
Malpas, J.S.3
|